IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

VIGANO', OTTAVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.114
EU - Europa 1.058
AS - Asia 474
SA - Sud America 38
AF - Africa 7
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.698
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.065
GB - Regno Unito 366
CN - Cina 179
IT - Italia 151
SE - Svezia 137
SG - Singapore 131
DE - Germania 126
RU - Federazione Russa 59
UA - Ucraina 49
CA - Canada 47
FR - Francia 43
IN - India 43
TR - Turchia 41
IE - Irlanda 34
KR - Corea 31
FI - Finlandia 30
EU - Europa 26
BR - Brasile 24
BE - Belgio 19
ID - Indonesia 18
NL - Olanda 16
CO - Colombia 11
GR - Grecia 10
HK - Hong Kong 9
DK - Danimarca 6
AU - Australia 4
JP - Giappone 4
TH - Thailandia 4
CI - Costa d'Avorio 3
ES - Italia 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
CL - Cile 2
IR - Iran 2
MX - Messico 2
PH - Filippine 2
RO - Romania 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AR - Argentina 1
AT - Austria 1
BG - Bulgaria 1
BH - Bahrain 1
ET - Etiopia 1
GA - Gabon 1
IL - Israele 1
IQ - Iraq 1
KE - Kenya 1
KH - Cambogia 1
LK - Sri Lanka 1
ME - Montenegro 1
MW - Malawi 1
NO - Norvegia 1
PT - Portogallo 1
Totale 2.722
Salva come PNG Salva come JPEG
Città #
Southend 326
Chandler 144
Fairfield 79
Singapore 78
Ann Arbor 67
Woodbridge 62
Milan 60
Seattle 56
Ashburn 52
Wilmington 50
Houston 45
Princeton 43
Dearborn 38
Santa Clara 37
Beijing 34
Dublin 34
Cambridge 28
Jacksonville 27
Toronto 26
Redmond 24
Brussels 19
Boardman 18
Jakarta 18
Somerville 16
Nanjing 15
Montreal 14
Mountain View 14
Sakarya 14
Bengaluru 13
Helsinki 13
Phoenix 12
Andover 11
Bogotá 11
Des Moines 11
Athens 10
Redwood City 10
Shanghai 10
Grafing 8
Kent 8
Serra 8
Tianjin 8
Guangzhou 7
Los Angeles 7
Seoul 7
Turin 7
Frankfurt am Main 6
Hebei 6
Jinan 6
Margão 6
Nürnberg 6
Padova 6
Rome 6
Silver Spring 6
São Paulo 6
Wuhan 5
Yubileyny 5
Berlin 4
Eitensheim 4
Fuzhou 4
Hong Kong 4
Mumbai 4
Nanchang 4
Quanzhou 4
San Diego 4
Shenyang 4
Auburn Hills 3
Falls Church 3
Fremont 3
Kunming 3
Kwai Chung 3
Lanzhou 3
Lissone 3
Munich 3
Palaiseau 3
Paris 3
Verona 3
Atlanta 2
Bangkok 2
Bari 2
Brasília 2
Brescia 2
Casorate Primo 2
Changsha 2
Florence 2
Gioia del Colle 2
Halethorpe 2
Jiaxing 2
Kiez 2
London 2
Manila 2
Medford 2
New York 2
Odernheim 2
Oklahoma City 2
Ottawa 2
Pittsburgh 2
San Francisco 2
Sayreville 2
Sydney 2
Taipei 2
Totale 1.780
Salva come PNG Salva come JPEG
Nome #
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens 233
Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir 230
Abacavir hypersensitivity reaction after switching from the twice-daily to the once-daily formulation 209
Does GSS Still Maintain Relevance on HAART Outcome After the Introduction of Newest Active Antiretroviral Drugs? 48 Weeks Results 194
Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV : experience in a pediatric population 190
New macrocyclic amines showing activity as HIV entry inhibitors against wild type and multi-drug resistant viruses 177
Analysis of protease inhibitor combinations in vitro : activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates 171
Unusual codon 69 insertions : influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility 160
Efficacia di Caspofungin nella candidosi esofagea HIV-correlata multifarmacoresistente 160
Predictive factors of therapeutic success of a HAART regimen including atazanavir with or without ritonavir in HIV-infected patients 150
Absence of new thymidine-associated mutations and evidence of an immune virologic response over a 12-month period in a cohort of antiretroviral- experienced HIV-1-infected subjects treated with tenofovir combination therapy [2] 133
Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatmentefficacy in UGT1A1*28 polymorphism carriers 126
Successful rescue therapy with Raltegravir (MK-0518) and Etravirine (TMC125) in an HIV-infected patient failing all four classes of antiretroviral drugs 120
Efficacy, tolerability and virological consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patients 92
Haemoptysis and fever in a young refugee from Somalia 87
Resolution of multidrug-refractory oesophageal candidiasis in an AIDS patient after treatment with caspofungin 84
New HIV protease inhibitors for drug-resistant viruses 84
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients : a randomized, controlled, pilot study (the REYAGEN study) 82
Female gender is associated with long COVID syndrome : a prospective cohort study 72
Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19 60
Three case reports of West Nile virus neuroinvasive disease: lessons from real-life clinical practice 45
Totale 2.859
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.915
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.915
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020230 0 0 0 0 0 59 47 18 44 37 15 10
2020/2021302 12 19 32 6 28 19 17 21 41 19 67 21
2021/2022265 33 9 11 9 14 11 20 22 50 26 11 49
2022/2023409 41 46 39 53 33 86 6 33 51 2 15 4
2023/2024232 13 20 16 29 38 13 17 14 3 11 19 39
2024/2025271 18 54 12 93 70 24 0 0 0 0 0 0
Totale 2.859